University of Liege
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- Private
- Established
- 1817-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.ulg.ac.be
Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)
Phase 2
Completed
- Conditions
- Hematological Malignancies
- Interventions
- First Posted Date
- 2007-11-14
- Last Posted Date
- 2010-01-11
- Lead Sponsor
- University of Liege
- Target Recruit Count
- 125
- Registration Number
- NCT00557817
- Locations
- 🇧🇪
Katholieke Universiteit Leuven, Leuven, Belgium
🇧🇪Vrije Universiteit Brussel, Brussels, Belgium
🇧🇪CHR la citadelle, Liege, Belgium
Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease
Phase 2
Completed
- Conditions
- Hematological Malignancies
- Interventions
- Procedure: Mesenchymal stem cell infusion
- First Posted Date
- 2007-07-20
- Last Posted Date
- 2011-09-02
- Lead Sponsor
- University of Liege
- Target Recruit Count
- 30
- Registration Number
- NCT00504803
- Locations
- 🇧🇪
CHU Sart Tilman, Liege, Belgium
Glucontrol Study: Comparing the Effects of Two Glucose Control Regimens by Insulin in Intensive Care Unit Patients
Not Applicable
Completed
- Conditions
- Critical Illness
- First Posted Date
- 2005-04-06
- Last Posted Date
- 2008-06-27
- Lead Sponsor
- University of Liege
- Target Recruit Count
- 3500
- Registration Number
- NCT00107601
- Locations
- 🇳🇱
V.U.Z. Amsterdam, Amsterdam, Netherlands
🇨🇭C.H.U. Vaudois, Lausanne, Switzerland
🇪🇸Hospital Universitario General Negrin, Las Palmas de Gran Canaria, Spain
© Copyright 2025. All Rights Reserved by MedPath